Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMidwest Biomedical Research Foundation

About this trial

The purpose of this study is to determine or evaluate the risk factors such as smoking, family history etc. that cause esophageal cancer and to determine the genetic changes that lead to esophageal cancer. The investigators hypothesis is that systematic collection of data on the natural history of GERD and BE patients and risk factors for development of BE in patients with chronic GERD and progression of BE to dysplasia and adenocarcinoma will provide useful information to develop a decision model for risk stratification and risk reduction strategies in these patients.

As of March 17, 2011, 585 patients have consented at the Kansas City VA Medical Center.

Eligibility criteria

Qualifiers

Kansas City VA Patients with confirmed BE with and without dysplasia and patients with reflux disease (patients/cases); patients with other indicators for endoscopy such as anemia, weight loss, diarrhea, but without GERD and PE (controls).

Disqualifiers

Patients with uncontrolled significant comorbidities such as cardiovascular, pulmonary, renal, hepatic or metabolic diseases.

Presence of anticoagulation that would increase risk from biopsies

Patients unable to provide history

Patients with dyspepsia

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

3,000 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Midwest Biomedical Research Foundation

Lead sponsor

Kansas City Veteran Affairs Medical Center

Collaborator